XW0G7R7Introduction of Fostamatinib into Upper GI, Via Natural or Artificial Opening, New Technology Group 7

New Technology›Anatomical Regions›Introduction

Billable / Specific Code

ICD-10-PCS XW0G7R7

CMS Source: FY 2026 ICD-10-PCS dataset. Effective Oct 1, 2025 – Sep 30, 2026.

XW0G7R7 is a billable ICD-10-PCS procedure code for Introduction of Fostamatinib into Upper GI, Via Natural or Artificial Opening, New Technology Group 7. It is valid on HIPAA claims for fiscal year 2026 (October 1, 2025 through September 30, 2026). The root operation Introduction involves putting in or on a therapeutic, diagnostic, nutritional, physiological, or prophylactic substance except blood or blood products. In AHRQ's Clinical Classifications Software (CCSR), this procedure falls under Administration of anti-inflammatory agents.

Code Identity

ICD-10-PCS Code

XW0G7R7

Billable Status

Yes — Valid for Submission

Code Describes

Introduction of Fostamatinib into Upper GI, Via Natural or Artificial Opening, New Technology Group 7

Short Description

Introduce Fostamatinib in Up GI, Via Opening, New Tech 7

Parent Code

XW0

PCS Table Breakdown

Each ICD-10-PCS code is built from seven characters, each an axis of the procedure. Hover or tap the icons for the official CMS definitions.

Position	Designation	Value	Meaning
1	Section	X	New Technology
2	Body System	W	Anatomical Regions
3	Operation	0	Introduction
4	BodyPart	G	Upper GI
5	Approach	7	Via Natural or Artificial Opening
6	Device/Substance/Technology	R	Fostamatinib
7	Qualifier	7	New Technology Group 7

Clinical Classification (CCSR)

AHRQ groups XW0G7R7 into these clinical categories.

ADM016

Administration of anti-inflammatory agents

Clinical domain: Administration of Therapeutic Substances

Code History

Replaces previously assigned code(s):

3E0G7GC — Introduction of Oth Therap Subst into Up GI, Via Opening

Similar Procedure Codes

Questions About XW0G7R7

Is XW0G7R7 a billable code?

Yes. XW0G7R7 is a complete seven-character ICD-10-PCS code, specific enough to report Introduction of Fostamatinib into Upper GI, Via Natural or Artificial Opening, New Technology Group 7 on inpatient claims from October 1, 2025 through September 30, 2026.

What do the characters in XW0G7R7 mean?

XW0G7R7 breaks down character by character: the 1st character X is the Section (New Technology); the 2nd character W is the Body System (Anatomical Regions); the 3rd character 0 is the Operation (Introduction); the 4th character G is the BodyPart (Upper GI); the 5th character 7 is the Approach (Via Natural or Artificial Opening); the 6th character R is the Device/Substance/Technology (Fostamatinib); the 7th character 7 is the Qualifier (New Technology Group 7).